MyFinsight
Home
Blog
About
Marketable securities
$142,917K
(-51.05%↓ Y/Y)
Cash and cash
equivalents
$76,548K
(-12.74%↓ Y/Y)
Prepaid expenses and
other current assets
$9,200K
(56.17%↑ Y/Y)
Total current assets
$228,665K
(-40.70%↓ Y/Y)
Other assets
$3,048K
(-30.63%↓ Y/Y)
Operating lease
right-of-use assets, net
$320K
(-66.03%↓ Y/Y)
Property and equipment,
net
$249K
(-62.56%↓ Y/Y)
Total assets
$232,282K
(-40.68%↓ Y/Y)
Total liabilities and
stockholders equity
$232,282K
(-40.68%↓ Y/Y)
Total stockholders
equity
$204,158K
(-43.98%↓ Y/Y)
Total current
liabilities
$28,124K
(39.79%↑ Y/Y)
Accumulated deficit
-$600,942K
(-37.94%↓ Y/Y)
Accumulated other
comprehensive (loss) gain
-$96K
(-359.46%↓ Y/Y)
Additional paid-in capital
$805,116K
(0.65%↑ Y/Y)
Accrued expenses and
other current...
$17,642K
(68.76%↑ Y/Y)
Accounts payable
$10,058K
(13.73%↑ Y/Y)
Current portion of
operating lease...
$424K
(-48.36%↓ Y/Y)
Common stock, 0.001 par
value 300,000,000...
$80K
(-1.23%↓ Y/Y)
Back
Back
Balance Sheet
Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc. (AVIR)
source: myfinsight.com